New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
24th March 2023
9th March 2023
3rd March 2023
3rd March 2023
4th March 2022
21st February 2022
Washington State: House Bill 2122 has been introduced. The bill would comprehensively regulate intoxicating cannabinoid products by defining and categorising “artificial cannabinoids” and “synthetically derived cannabinoids”, and designating any product with 0.5 mg of THC per serving and 2 mg of THC per package as a “marijuana product”, among other things.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.